Role of Hematopoietic Cell Transplantation in Pediatric and Adult Hemophagocytic Lymphohistiocytosis-Remaining Unknowns and Challenges.
Hematology/oncology clinics of North America. 2025 Jun; 39(Jun):645-660. doi: 10.1016/j.hoc.2025.03.002. pii: S0889-8588(25)00027-9.
Base: PUBMEDImmune Effector Cell-associated Hemophagocytic Lymphohistiocytosis-like Syndrome (IEC-HS).
Hematology/oncology clinics of North America. 2025 Jun; 39(Jun):617-643. doi: 10.1016/j.hoc.2025.02.005. pii: S0889-8588(25)00020-6.
Base: PUBMEDMacrophage Activation Syndrome: Not Just for Rheumatologists Anymore.
Hematology/oncology clinics of North America. 2025 Jun; 39(Jun):597-615. doi: 10.1016/j.hoc.2025.02.004. pii: S0889-8588(25)00019-X.
Base: PUBMEDRecognizing and Managing Secondary Hemophagocytic Lymphohistiocytosis in Adults: A Practical Clinical Guide.
Hematology/oncology clinics of North America. 2025 Jun; 39(Jun):577-596. doi: 10.1016/j.hoc.2025.02.007. pii: S0889-8588(25)00025-5.
Base: PUBMEDClinical Characteristics and Treatment of Familial Hemophagocytic Lymphohistiocytosis.
Hematology/oncology clinics of North America. 2025 Jun; 39(Jun):553-575. doi: 10.1016/j.hoc.2025.02.003. pii: S0889-8588(25)00018-8.
Base: PUBMEDGenetics of Familial Hemophagocytic Lymphohistiocytosis (HLH).
Hematology/oncology clinics of North America. 2025 Jun; 39(Jun):531-551. doi: 10.1016/j.hoc.2025.02.002. pii: S0889-8588(25)00017-6.
Base: PUBMEDGenomic Alterations in Langerhans Cell Histiocytosis.
Hematology/oncology clinics of North America. 2025 Jun; 39(Jun):491-511. doi: 10.1016/j.hoc.2025.02.001. pii: S0889-8588(25)00016-4.
Base: PUBMEDMolecular Pathogenesis of the Histiocytic and Dendritic Cell Neoplasms.
Hematology/oncology clinics of North America. 2025 Jun; 39(Jun):471-490. doi: 10.1016/j.hoc.2025.03.001. pii: S0889-8588(25)00026-7.
Base: PUBMEDRelacorilant and nab-paclitaxel in patients with platinum-resistant ovarian cancer (ROSELLA): an open-label, randomised, controlled, phase 3 trial.
Lancet (London, England). 2025 Jun; 405(Jun):2205-2216. doi: 10.1016/S0140-6736(25)01040-2. pii: S0140-6736(25)01040-2.
Base: PUBMED[Management of follicular cell-derived thyroid cancer in 2025].
Revue medicale suisse. 2025 Jun; 21(Jun):1210-1215. doi: 10.53738/REVMED.2025.21.922.47328. pii: .
Base: PUBMEDRisk of Surgical Overtreatment in cN1 Breast Cancer Patients who Become ypN0 After Neoadjuvant Chemotherapy: SLNB Versus TAD.
Annals of surgical oncology. 2025 Mar; 32(Mar):2023-2028. doi: 10.1245/s10434-024-16625-7. pii: .
Base: PUBMEDAtrial fibrillation and ischemic stroke in cancer: the latest scientific evidence, current management, and future directions.
Journal of thrombosis and thrombolysis. 2025 Apr; doi: 10.1007/s11239-025-03104-3. pii: .
Base: PUBMEDOmitting Regional Nodal Irradiation after Response to Neoadjuvant Chemotherapy.
The New England journal of medicine. 2025 Jun; 392(Jun):2113-2124. doi: 10.1056/NEJMoa2414859. pii: .
Base: PUBMEDClinical Characteristics and Treatment of Histiocytic Disorders in Children.
Hematology/oncology clinics of North America. 2025 Jun; 39(Jun):513-529. doi: 10.1016/j.hoc.2025.02.006. pii: S0889-8588(25)00024-3.
Base: PUBMEDGreat Debate: Does Breast-Conserving Surgery with Radiotherapy Offer Better Survival than Mastectomy in Early-Stage Breast Cancer?
Annals of surgical oncology. 2025 Jul; 32(Jul):4590-4596. doi: 10.1245/s10434-025-17333-6. pii: .
Base: PUBMEDGenetic origin of multifocal sporadic medullary thyroid cancer and C-cell hyperplasia.
European journal of endocrinology. 2025 May; 192(May):737-743. doi: 10.1093/ejendo/lvaf109. pii: .
Base: PUBMEDLess is more: once vs. multiple radioactive iodine (RAI) therapy in patients with RAI-avid pulmonary micrometastatic differentiated thyroid cancer.
European journal of nuclear medicine and molecular imaging. 2025 May; doi: 10.1007/s00259-025-07339-3. pii: .
Base: PUBMEDThe diagnostic challenges of medullary thyroid carcinoma: A practical guide for cytopathologists.
Cancer cytopathology. 2025 Jun; 133(Jun):e70023. doi: 10.1002/cncy.70023. pii: e70023.
Base: PUBMEDThe utility of 68Ga-DOTATATE and 18F-FDG PET/CT in predicting the response to tyrosine kinase inhibitors in patients with advanced medullary thyroid cancer.
Thyroid research. 2025 Jun; 18(Jun):31. doi: 10.1186/s13044-025-00250-x. pii: 31.
Base: PUBMEDAdjuvant External Beam Radiotherapy Reduces Local Recurrence in Poorly Differentiated Thyroid Cancer : A Multicenter Retrospective Cohort Study Describing Outcomes in the Treatment of Resectable Poorly Differentiated Thyroid Cancer.
Annals of surgical oncology. 2025 May; doi: 10.1245/s10434-025-17434-2. pii: .
Base: PUBMEDASO Visual Abstract: Adjuvant External Beam Radiotherapy Reduces Local Recurrence in Poorly Differentiated Thyroid Cancer : A Multicenter Retrospective Cohort Study Describing Outcomes in the Treatment of Resectable Poorly Differentiated Thyroid Cancer.
Annals of surgical oncology. 2025 Jun; doi: 10.1245/s10434-025-17583-4. pii: .
Base: PUBMEDGastric cancer.
Lancet (London, England). 2025 Jun; 405(Jun):2087-2102. doi: 10.1016/S0140-6736(25)00052-2. pii: S0140-6736(25)00052-2.
Base: PUBMEDPancreatic cancer.
Lancet (London, England). 2025 Apr; 405(Apr):1182-1202. doi: 10.1016/S0140-6736(25)00261-2. pii: S0140-6736(25)00261-2.
Base: PUBMEDEndocrinological toxicities related to immunotherapy combinations for advanced renal cell carcinoma: Practical expert-based management recommendations.
Critical reviews in oncology/hematology. 2025 May; 209(May):104627. doi: 10.1016/j.critrevonc.2025.104627. pii: S1040-8428(25)00015-0.
Base: PUBMEDNovel Postneoadjuvant Prognostic Breast Cancer Staging System.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2025 Jun; 43(Jun):1948-1960. doi: 10.1200/JCO-24-01739. pii: .
Base: PUBMEDRadiotherapy in cutaneous lymphomas: Recommendations from the EORTC cutaneous lymphoma tumour group.
European journal of cancer (Oxford, England : 1990). 2024 Nov; 212(Nov):115064. doi: 10.1016/j.ejca.2024.115064. pii: S0959-8049(24)01030-X.
Base: PUBMEDAcute Lymphoblastic Leukemia, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology.
Journal of the National Comprehensive Cancer Network : JNCCN. 2024 Oct; 22(Oct):563-576. doi: 10.6004/jnccn.2024.0051. pii: .
Base: PUBMEDNCCN Guidelines® Insights: Ovarian Cancer/Fallopian Tube Cancer/Primary Peritoneal Cancer, Version 3.2024.
Journal of the National Comprehensive Cancer Network : JNCCN. 2024 Oct; 22(Oct):512-519. doi: 10.6004/jnccn.2024.0052. pii: .
Base: PUBMEDChallenges and opportunities for early phase clinical trials of novel drug-radiotherapy combinations: recommendations from NRG Oncology, the American Society for Radiation Oncology (ASTRO), the American College of Radiology (ACR), the Sarah Cannon Research Institute, and the American College of Radiation Oncology (ACRO).
The Lancet. Oncology. 2024 Oct; 25(Oct):e489-e500. doi: 10.1016/S1470-2045(24)00264-X. pii: S1470-2045(24)00264-X.
Base: PUBMEDCutaneous melanoma: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.
Annals of oncology : official journal of the European Society for Medical Oncology. 2025 Jan; 36(Jan):10-30. doi: 10.1016/j.annonc.2024.11.006. pii: S0923-7534(24)04912-3.
Base: PUBMEDManagement of Locally Advanced Rectal Cancer: ASCO Guideline.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2024 Oct; 42(Oct):3355-3375. doi: 10.1200/JCO.24.01160. pii: .
Base: PUBMEDA joint ESTRO and AAPM guideline for development, clinical validation and reporting of artificial intelligence models in radiation therapy.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology. 2024 Aug; 197(Aug):110345. doi: 10.1016/j.radonc.2024.110345. pii: S0167-8140(24)00615-7.
Base: PUBMEDEASL-ILCA Clinical Practice Guidelines on the management of intrahepatic cholangiocarcinoma.
Journal of hepatology. 2023 Jul; 79(Jul):181-208. doi: 10.1016/j.jhep.2023.03.010. pii: S0168-8278(23)00185-X.
Base: PUBMEDMultidisciplinary Treatment of Hepatocellular Carcinoma in 2023: Italian practice Treatment Guidelines of the Italian Association for the Study of the Liver (AISF), Italian Association of Medical Oncology (AIOM), Italian Association of Hepato-Bilio-Pancreatic Surgery (AICEP), Italian Association of Hospital Gastroenterologists (AIGO), Italian Association of Radiology and Clinical Oncology (AIRO), Italian Society of Pathological Anatomy and Diagnostic Cytology (SIAPeC-IAP), Italian Society of Surgery (SIC), Italian Society of Gastroenterology (SIGE), Italian Society of Medical and Interventional Radiology (SIRM), Italian Organ Transplant Society (SITO), and Association of Patients with Hepatitis and Liver Disease (EpaC) - Part I - Surgical treatments.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver. 2024 Feb; 56(Feb):223-234. doi: 10.1016/j.dld.2023.10.029. pii: S1590-8658(23)01019-8.
Base: PUBMEDCannabis and Cannabinoids in Adults With Cancer: ASCO Guideline.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2024 May; 42(May):1575-1593. doi: 10.1200/JCO.23.02596. pii: .
Base: PUBMEDNCCN Guidelines® Insights: Rectal Cancer, Version 3.2024.
Journal of the National Comprehensive Cancer Network : JNCCN. 2024 Aug; 22(Aug):366-375. doi: 10.6004/jnccn.2024.0041. pii: .
Base: PUBMEDInternational Anal Neoplasia Society's consensus guidelines for anal cancer screening.
International journal of cancer. 2024 May; 154(May):1694-1702. doi: 10.1002/ijc.34850. pii: .
Base: PUBMEDEAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer-2024 Update. Part I: Screening, Diagnosis, and Local Treatment with Curative Intent.
European urology. 2024 Aug; 86(Aug):148-163. doi: 10.1016/j.eururo.2024.03.027. pii: S0302-2838(24)02254-1.
Base: PUBMED6th and 7th International consensus guidelines for the management of advanced breast cancer (ABC guidelines 6 and 7).
Breast (Edinburgh, Scotland). 2024 Aug; 76(Aug):103756. doi: 10.1016/j.breast.2024.103756. pii: 103756.
Base: PUBMEDBreast Cancer, Version 3.2024, NCCN Clinical Practice Guidelines in Oncology.
Journal of the National Comprehensive Cancer Network : JNCCN. 2024 Jul; 22(Jul):331-357. doi: 10.6004/jnccn.2024.0035. pii: .
Base: PUBMEDAGA Clinical Practice Update on Risk Stratification for Colorectal Cancer Screening and Post-Polypectomy Surveillance: Expert Review.
Gastroenterology. 2023 Nov; 165(Nov):1280-1291. doi: 10.1053/j.gastro.2023.06.033. pii: S0016-5085(23)04771-6.
Base: PUBMEDBritish Gynaecological Cancer Society (BGCS) ovarian, tubal and primary peritoneal cancer guidelines: Recommendations for practice update 2024.
European journal of obstetrics, gynecology, and reproductive biology. 2024 Sep; 300(Sep):69-123. doi: 10.1016/j.ejogrb.2024.06.025. pii: S0301-2115(24)00314-2.
Base: PUBMEDAmerican Society for Gastrointestinal Endoscopy guideline on endoscopic submucosal dissection for the management of early esophageal and gastric cancers: methodology and review of evidence.
Gastrointestinal endoscopy. 2023 Sep; 98(Sep):285-305.e38. doi: 10.1016/j.gie.2023.03.030. pii: S0016-5107(23)00371-1.
Base: PUBMEDVulvar Cancer, Version 3.2024, NCCN Clinical Practice Guidelines in Oncology.
Journal of the National Comprehensive Cancer Network : JNCCN. 2024 Mar; 22(Mar):117-135. doi: 10.6004/jnccn.2024.0013. pii: .
Base: PUBMEDEuropean guidelines for the diagnosis, treatment and follow-up of breast lesions with uncertain malignant potential (B3 lesions) developed jointly by EUSOMA, EUSOBI, ESP (BWG) and ESSO.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology. 2024 Jan; 50(Jan):107292. doi: 10.1016/j.ejso.2023.107292. pii: S0748-7983(23)00930-7.
Base: PUBMEDAnal Carcinoma, Version 2.2023, NCCN Clinical Practice Guidelines in Oncology.
Journal of the National Comprehensive Cancer Network : JNCCN. 2023 Jun; 21(Jun):653-677. doi: 10.6004/jnccn.2023.0030. pii: .
Base: PUBMEDInternational multidisciplinary consensus on the integration of radiotherapy with new systemic treatments for breast cancer: European Society for Radiotherapy and Oncology (ESTRO)-endorsed recommendations.
The Lancet. Oncology. 2024 Feb; 25(Feb):e73-e83. doi: 10.1016/S1470-2045(23)00534-X. pii: S1470-2045(23)00534-X.
Base: PUBMEDScreening for lung cancer: 2023 guideline update from the American Cancer Society.
CA: a cancer journal for clinicians. 2024 ; 74():50-81. doi: 10.3322/caac.21811. pii: .
Base: PUBMEDNICE 2022 guidelines on the management of melanoma: Update and implications.
Journal of plastic, reconstructive & aesthetic surgery : JPRAS. 2023 Oct; 85(Oct):401-413. doi: 10.1016/j.bjps.2023.07.026. pii: S1748-6815(23)00439-4.
Base: PUBMEDAASLD Practice Guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma.
Hepatology (Baltimore, Md.). 2023 Dec; 78(Dec):1922-1965. doi: 10.1097/HEP.0000000000000466. pii: .
Base: PUBMEDHow can we optimize the surgical management of the axilla in breast cancer since the MonarchE trial?
Breast cancer research and treatment. 2025 Jul; 212(Jul):13-21. doi: 10.1007/s10549-025-07642-5. pii: .
Base: PUBMEDGreat Debate: Does Breast-Conserving Surgery with Radiotherapy Offer Better Survival than Mastectomy in Early-Stage Breast Cancer?
Annals of surgical oncology. 2025 Jul; 32(Jul):4590-4596. doi: 10.1245/s10434-025-17333-6. pii: .
Base: PUBMEDLimitations of locoregional and distant recurrence analysis after neoadjuvant chemotherapy.
Breast cancer research and treatment. 2025 Jul; 212(Jul):183-184. doi: 10.1007/s10549-025-07680-z. pii: .
Base: PUBMEDRelacorilant and nab-paclitaxel in patients with platinum-resistant ovarian cancer (ROSELLA): an open-label, randomised, controlled, phase 3 trial.
Lancet (London, England). 2025 Jun; 405(Jun):2205-2216. doi: 10.1016/S0140-6736(25)01040-2. pii: S0140-6736(25)01040-2.
Base: PUBMEDThe utility of 68Ga-DOTATATE and 18F-FDG PET/CT in predicting the response to tyrosine kinase inhibitors in patients with advanced medullary thyroid cancer.
Thyroid research. 2025 Jun; 18(Jun):31. doi: 10.1186/s13044-025-00250-x. pii: 31.
Base: PUBMED[Management of follicular cell-derived thyroid cancer in 2025].
Revue medicale suisse. 2025 Jun; 21(Jun):1210-1215. doi: 10.53738/REVMED.2025.21.922.47328. pii: .
Base: PUBMEDNovel Postneoadjuvant Prognostic Breast Cancer Staging System.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2025 Jun; 43(Jun):1948-1960. doi: 10.1200/JCO-24-01739. pii: .
Base: PUBMEDASO Visual Abstract: Adjuvant External Beam Radiotherapy Reduces Local Recurrence in Poorly Differentiated Thyroid Cancer : A Multicenter Retrospective Cohort Study Describing Outcomes in the Treatment of Resectable Poorly Differentiated Thyroid Cancer.
Annals of surgical oncology. 2025 Jun; doi: 10.1245/s10434-025-17583-4. pii: .
Base: PUBMEDGastric cancer.
Lancet (London, England). 2025 Jun; 405(Jun):2087-2102. doi: 10.1016/S0140-6736(25)00052-2. pii: S0140-6736(25)00052-2.
Base: PUBMEDOmitting Regional Nodal Irradiation after Response to Neoadjuvant Chemotherapy.
The New England journal of medicine. 2025 Jun; 392(Jun):2113-2124. doi: 10.1056/NEJMoa2414859. pii: .
Base: PUBMED